{
    "id": 190,
    "entrez_name": "EGFR",
    "entrez_id": 1956,
    "name": "Amplification",
    "description": "",
    "gene_id": 19,
    "type": "variant",
    "variant_types": [
        {
            "id": 123,
            "name": "transcript_amplification",
            "display_name": "Transcript Amplification",
            "so_id": "SO:0001889",
            "description": "A feature amplification of a region containing a transcript.",
            "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0001889"
        }
    ],
    "civic_actionability_score": 133,
    "coordinates": {
        "chromosome": "7",
        "start": 55086794,
        "stop": 55279321,
        "reference_bases": null,
        "variant_bases": null,
        "representative_transcript": "ENST00000275493.2",
        "chromosome2": null,
        "start2": null,
        "stop2": null,
        "representative_transcript2": null,
        "ensembl_version": 75,
        "reference_build": "GRCh37"
    },
    "evidence_items": {
        "id": 5924,
        "name": "EID5924",
        "description": "The result of the analysis found that EGFR gene copy number was associated with increased OS and PFS, supporting the idea that EGFR gene copy number is a biomarker for response to EGFR-TKI therapy in patients with advanced NSCLC.",
        "disease": {
            "id": 8,
            "name": "Lung Non-small Cell Carcinoma",
            "display_name": "Lung Non-small Cell Carcinoma",
            "doid": "3908",
            "url": "http://www.disease-ontology.org/?id=DOID:3908"
        },
        "drugs": [
            {
                "id": 14,
                "name": "Gefitinib",
                "ncit_id": "C1855",
                "aliases": [
                    "ZD1839",
                    "ZD 1839",
                    "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) Propoxy]-4-quinazolinamine",
                    "Iressa",
                    "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline"
                ]
            },
            {
                "id": 15,
                "name": "Erlotinib",
                "ncit_id": "C65530",
                "aliases": []
            }
        ],
        "rating": 4,
        "evidence_level": "B",
        "evidence_type": "Predictive",
        "clinical_significance": "Sensitivity/Response",
        "evidence_direction": "Supports",
        "variant_origin": "Somatic",
        "drug_interaction_type": "Substitutes",
        "status": "accepted",
        "type": "evidence",
        "source": {
            "id": 650,
            "name": "EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.",
            "citation": "Dahabreh et al., 2011, Ann. Oncol.",
            "citation_id": "20826716",
            "source_type": "PubMed",
            "asco_abstract_id": null,
            "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/20826716",
            "open_access": null,
            "pmc_id": null,
            "publication_date": {
                "year": 2011,
                "month": 3
            },
            "journal": "Ann. Oncol.",
            "full_journal_title": "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",
            "status": "fully curated",
            "is_review": false,
            "clinical_trials": []
        },
        "variant_id": 190,
        "phenotypes": []
    },
    "variant_groups": [],
    "assertions": [],
    "variant_aliases": [],
    "hgvs_expressions": [
        "N/A"
    ],
    "clinvar_entries": [
        "N/A"
    ],
    "allele_registry_id": null
}